# Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age

> **NCT02774434** · NA · COMPLETED · sponsor: **Draeger Medical Systems, Inc.** · enrollment: 464 (actual)

## Conditions studied

- Hyperbilirubinemia
- Neonatal Jaundice

## Interventions

- **DEVICE:** JM-105

## Key facts

- **NCT ID:** NCT02774434
- **Lead sponsor:** Draeger Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774434, "Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02774434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*